Elanco Animal Health Incorporated (ELAN) Financials

$11.71

north_east
$0.01 (0.04%)
Day's range
$11.48
Day's range
$11.88

ELAN Income statement / Annual

Last year (2023), Elanco Animal Health Incorporated's total revenue was $4.42 B, a decrease of 0.02% from the previous year. In 2023, Elanco Animal Health Incorporated's net income was -$1.23 B. See Elanco Animal Health Incorporated,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $4.42 B $4.42 B $4.77 B $3.27 B $3.07 B $3.07 B $2.89 B $2.91 B $2.91 B
Cost of Revenue $2.48 B $1.91 B $2.13 B $1.67 B $1.47 B $1.57 B $1.49 B $1.41 B $1.53 B
Gross Profit $1.94 B $2.51 B $2.63 B $1.61 B $1.60 B $1.49 B $1.40 B $1.50 B $1.38 B
Gross Profit Ratio 0.44 0.57 0.55 0.49 0.52 0.49 0.48 0.52 0.47
Research and Development Expenses $327.00 M $321.00 M $369.00 M $327.00 M $270.10 M $246.60 M $251.70 M $265.80 M $291.00 M
General & Administrative Expenses $1.07 B $1.07 B $1.16 B $0.00 $0.00 $735.20 M $0.00 $0.00 $0.00
Selling & Marketing Expenses $207.00 M $201.00 M $248.00 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $1.29 B $1.27 B $1.40 B $996.60 M $760.20 M $735.20 M $779.80 M $784.80 M $916.00 M
Other Expenses $0.00 $528.00 M $556.00 M $359.90 M $200.40 M -$41.30 M $100,000.00 $2.80 M -$1.60 M
Operating Expenses $1.61 B $2.12 B $2.33 B $1.68 B $1.23 B $1.18 B $1.25 B $1.22 B $1.37 B
Cost And Expenses $4.09 B $4.03 B $4.46 B $3.35 B $2.70 B $2.75 B $2.75 B $2.63 B $2.90 B
Interest Income $0.00 $241.00 M $236.00 M $150.00 M $79.00 M $0.00 $0.00 $0.00 $0.00
Interest Expense $277.00 M $241.00 M $236.00 M $149.80 M $78.90 M $29.60 M $0.00 $0.00 $0.00
Depreciation & Amortization $694.00 M $682.00 M $716.00 M $516.90 M $314.50 M $296.00 M $318.40 M $254.40 M $236.90 M
EBITDA -$224.00 M $866.00 M $409.00 M -$76.80 M $471.60 M $439.70 M $85.80 M $232.00 M $242.30 M
EBITDA Ratio -0.05 0.2 0.18 0.14 0.18 0.21 0.29 0.19 0.17
Operating Income Ratio 0.07 0.08 0.06 0.03 0.11 0.1 0.05 0.1 0
Total Other Income/Expenses Net -$1.52 B -$456.00 M -$875.00 M -$590.00 M -$291.80 M -$199.70 M -$375.00 M -$305.60 M -$264.90 M
Income Before Tax -$1.20 B -$66.00 M -$567.00 M -$672.00 M $78.20 M $114.10 M -$232.60 M -$22.40 M -$259.50 M
Income Before Tax Ratio -0.27 -0.01 -0.12 -0.21 0.03 0.04 -0.08 -0.01 -0.09
Income Tax Expense $36.00 M $8.00 M -$95.00 M -$111.90 M $10.30 M $27.60 M $78.10 M $25.50 M -$48.70 M
Net Income -$1.23 B -$74.00 M -$472.00 M -$560.10 M $67.90 M $86.50 M -$310.70 M -$47.90 M -$210.80 M
Net Income Ratio -0.28 -0.02 -0.1 -0.17 0.02 0.03 -0.11 -0.02 -0.07
EPS -2.5 -0.15 -0.97 -1.27 0.18 0.28 -0.87 -0.13 -0.59
EPS Diluted -2.5 -0.15 -0.97 -1.27 0.18 0.28 -0.87 -0.13 -0.59
Weighted Average Shares Out $492.30 M $488.30 M $487.20 M $441.40 M $369.00 M $313.70 M $356.20 M $356.20 M $356.20 M
Weighted Average Shares Out Diluted $492.30 M $488.30 M $487.20 M $441.40 M $370.30 M $313.70 M $356.20 M $356.20 M $356.20 M
Link